News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing: 1–13
Matches: 13
Sources here: 9
Companies here: 2

Search results Stored financial headlines Latest headline 19:36, 12 August 2026

Active search

13 matching headlines

Ticker or company: MMEDMain company stories

Clear

Latest19:36 · 12 August 2026

TradingView Earnings

Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?

DexCom, Inc. DXCM is entering the second half of 2026 with healthier margins, broader reimbursement and a larger continuous glucose monitoring opportunity. The investment question is whether that improving setup is enough to justify a premium valuation. Growth catalysts remain visible across U.S. coverage, product upgrades and international expansion. Yet competition, litigation and a forward earnings multiple above …

Main company 🇺🇸 United States

Read at TradingView

Sharemaestro market context Stored weekly price path 24 weeks +9.0%

Just inNext headlines

15:25 12 Aug 2026

TradingView Earnings Main company 🇸🇦 Saudi Arabia

Enterprise value to revenue forward of Mohammed Hadi Al Rasheed and Partners Co. – TADAWUL:9601

9601 main company

Sharemaestro market context Price below Trend Line 52 weeks -13.1% · Next-week setup negative 43.1%

23:42 11 Aug 2026

Morningstar Market update Main company 🇺🇸 United States

MiniMed Poised to Roll Out New Innovations in Diabetes Devices but Has Yet to Dig a Moat

MiniMed, recently spun out from Medtronic, is focusing on innovation in diabetes device technology. The company, a leader in durable, tubed insulin pumps for Type 1 diabetes, faces increasing competition despite its historical market presence. An analyst note initiates coverage with a "no-moat" rating …

MMED main company

Sharemaestro market context Stored weekly price path 24 weeks +9.0%

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

20:10 10 Aug 2026

Simply Wall Street Earnings Main company 🇺🇸 United States

MiniMed Group (Nasdaq:MMED) - Stock Analysis

This stock analysis report for MiniMed Group (Nasdaq:MMED) provides an overview of the company's financial health, future growth prospects, past performance, and valuation. It highlights recent news including the launch of new insulin pump systems, board changes, and financial results, noting the company is …

MMED main company

Sharemaestro market context Stored weekly price path 24 weeks +9.0%

13:10 10 Aug 2026

www.marketscreener.com Analyst action Main company 🇺🇸 United States

BofA Securities Adjusts MiniMed Group Price Target to $24 From $20

BofA Securities has raised its price target for MiniMed Group (MMED) shares to $24 from $20. This adjustment follows UBS initiating coverage on MiniMed Group with a Buy rating and a $25 price target on July 29th. MiniMed Group, a medical technology company specializing …

MMED main company

Sharemaestro market context Stored weekly price path 24 weeks +9.0%

11:43 10 Aug 2026

Investing.com Canada Analyst action Main company 🇺🇸 United States

BofA raises MiniMed Group stock price target to $24 on exchange timing

BofA Securities has raised its price target for MiniMed Group (NASDAQ: MMED) shares to $24 from $20, while maintaining a Buy rating. The increase is attributed to the approaching potential window for Medtronic to exchange its 90% ownership in MiniMed Group for Medtronic shares. …

MMED main company

Sharemaestro market context Stored weekly price path 24 weeks +9.0%

10:17 6 Aug 2026

Stock Titan Market update Main company 🇺🇸 United States

MiniMed Group (NASDAQ: MMED) says General Counsel Courtney Nelson Wills will step down

MiniMed Group (NASDAQ: MMED) announced that its Senior Vice President, General Counsel, and Corporate Secretary, Courtney Nelson Wills, will resign effective September 25, 2026. Ms. Wills notified the company on July 30, 2026, and her departure is due to personal reasons, as she has …

MMED main company

Sharemaestro market context Stored weekly price path 24 weeks +9.0%

10:17 4 Aug 2026

MarketBeat Earnings Main company 🇺🇸 United States

MiniMed Group Inc (NASDAQ:MMED) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Analysts have given MiniMed Group Inc (NASDAQ:MMED) a "Moderate Buy" consensus recommendation, with 13 buy ratings, two holds, and one sell from 16 firms. The average 12-month price target is $21.62, higher than the stock's opening price of $18.05. Despite mixed recent analyst actions …

MMED main company

Sharemaestro market context Stored weekly price path 24 weeks +9.0%

06:48 3 Aug 2026

TradingView Earnings Main company 🇸🇦 Saudi Arabia

Price to earnings forward of Mohammed Hadi Al Rasheed and Partners Co. – TADAWUL:9601

9601 main company

Sharemaestro market context Price below Trend Line 52 weeks -13.1% · Next-week setup negative 43.1%

08:00 29 Jul 2026

marketscreener.com Market update Main company 🇸🇦 Saudi Arabia

Mohammed Hadi Al Rasheed & Partners Company Announces Latest Developments Regarding Shariah-Compliant Banking Facilities Obtained from the Saudi Awwal Bank

9601 main company

Sharemaestro market context Price below Trend Line 52 weeks -13.1% · Next-week setup negative 43.1%

13:43 27 Jul 2026

Market source Earnings Main company 🇺🇸 United States

MMED Gets Medicare Coverage for Flex and Broadens Diabetes Care Access

MiniMed Group, Inc. (MMED) announced that its MiniMed Flex system, an app-controlled insulin pump, is now covered by Medicare and Medicare Advantage in the U.S., expanding access for diabetes patients. This move is expected to bolster MMED's market presence and revenue opportunities by increasing …

MMED main company

Sharemaestro market context Stored weekly price path 24 weeks +9.0%

10:17 26 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

MiniMed Group, Inc. Revenue Breakdown – NASDAQ:MMED

MiniMed Group, Inc. (NASDAQ: MMED) generated $3.10 billion USD in total revenue last year. Its top-performing segment, Continuous Glucose Monitoring, contributed $1.55 billion USD. The "Rest of World" region was the largest contributor to revenue, accounting for $2.19 billion USD.

MMED main company

Sharemaestro market context Stored weekly price path 24 weeks +9.0%

08:00 5 Feb 2026

Market source Market update Main company 🇸🇦 Saudi Arabia

Mohammed Hadi Al-Rasheed And 2 Emerging Middle East Small Caps with Promising Potential

9601 main company

Sharemaestro market context Price below Trend Line 52 weeks -13.1% · Next-week setup negative 43.1%

Search the Newsreel

13 matching headlines

Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?

Enterprise value to revenue forward of Mohammed Hadi Al Rasheed and Partners Co. – TADAWUL:9601

MiniMed Poised to Roll Out New Innovations in Diabetes Devices but Has Yet to Dig a Moat

Matching headlines

MiniMed Group (Nasdaq:MMED) - Stock Analysis

BofA Securities Adjusts MiniMed Group Price Target to $24 From $20

BofA raises MiniMed Group stock price target to $24 on exchange timing

MiniMed Group (NASDAQ: MMED) says General Counsel Courtney Nelson Wills will step down

MiniMed Group Inc (NASDAQ:MMED) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Price to earnings forward of Mohammed Hadi Al Rasheed and Partners Co. – TADAWUL:9601

Mohammed Hadi Al Rasheed & Partners Company Announces Latest Developments Regarding Shariah-Compliant Banking Facilities Obtained from the Saudi Awwal Bank

MMED Gets Medicare Coverage for Flex and Broadens Diabetes Care Access

MiniMed Group, Inc. Revenue Breakdown – NASDAQ:MMED

Mohammed Hadi Al-Rasheed And 2 Emerging Middle East Small Caps with Promising Potential

Search the Newsreel

Send a message

Evidence context